News
Innogen bets on longer-lasting GLP-1 drugs to stand out in crowded field
The company hopes to stand out with Diabegone, a diabetes treatment that lasts longer than competing drugs from companies like Novo Nordisk and Eli Lilly.
36Kr is China's most influential business and technology network, delivering high-quality content focused on China’s innovation and new economy trends since 2010. With its extensive traffic and network, 36Kr has built a comprehensive database and strong data analytics capabilities to provide insights into China’s technology landscape.
News
The company hopes to stand out with Diabegone, a diabetes treatment that lasts longer than competing drugs from companies like Novo Nordisk and Eli Lilly.